Literature DB >> 7083126

Neutrophil-mediated tumor cell destruction in cancer ascites.

M Katano, M Torisu.   

Abstract

Intraperitoneal injections of OK-432, originated from Group A streptococcus pyogens of human origin, were administered to 77 patients with ascites caused by cancer of the digestive tract. Complete disappearance of effusion was observed in 43 cases, its reduction in five out of 77. They received cytologic examination of ascites daily before and after OK-432 injection. One of these patients, a 77-year-old man with carcinomatous peritonitis due to gastric cancer, showed an interesting phenomenon after OK-432 injection. All adenocarcinoma cells in his ascites disappeared at least with 36 hours after OK-432 injection with increasing number of intraperitoneal neutrophils. In addition, neutrophils collected from his ascites or peripheral blood showed cytostatic effect on his ascites-derived tumor cells in vitro. His neutrophil-depleted intraperitoneal cells, however, had no significant effect on DNA synthesis of his tumor cells in vitro. OK-432 itself had no significant effect on DNA synthesis of his tumor cells in vitro. This report describes a patient in whom OK-432-induced neutrophils may play an important role in his tumor cell destruction in ascites.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7083126     DOI: 10.1002/1097-0142(19820701)50:1<62::aid-cncr2820500113>3.0.co;2-0

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  22 in total

1.  The analysis of cytostatic activity of human peripheral blood granulocytes and its augmentation with Nocardia rubra cell wall skeleton (N-CWS).

Authors:  E Shimizu; N Saijo; M Shibuya; T Takizawa; A Hoshi
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

Review 2.  Malignant ascites: pathophysiology and treatment.

Authors:  Emanuel Cavazzoni; Walter Bugiantella; Luigina Graziosi; Maria Silvia Franceschini; Annibale Donini
Journal:  Int J Clin Oncol       Date:  2012-03-31       Impact factor: 3.402

3.  The clinical efficacy of intratumoral OK-432 administration in advanced cancer patients.

Authors:  T Toge; H Kuninobu; Y Yamaguchi; N Baba; Y Kegoya; T Hattori
Journal:  Jpn J Surg       Date:  1988-11

4.  Postoperative chemotherapy including intraperitoneal and intradermal administration of the streptococcal preparation OK-432 for patients with gastric cancer and peritoneal dissemination: a prospective randomized study.

Authors:  K Sugimachi; Y Maehara; K Akazawa; Y Kondo; Y Kunii; M Kitamura; H Yamaoka; Y Takahashi; T Kito; M Katou
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

5.  Effect of picibanil (OK432) on neutrophil-mediated antitumor activity: implication of monocyte-derived neutrophil-activating factors.

Authors:  K D Yang; R M Stone; C S Lee; T Y Chao; S N Cheng; M F Shaio
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

6.  Antitumor effect induced by a hot water extract of Chlorella vulgaris (CE): resistance to Meth-A tumor growth mediated by CE-induced polymorphonuclear leukocytes.

Authors:  F Konishi; K Tanaka; K Himeno; K Taniguchi; K Nomoto
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

7.  Effects of the oral or intratumoral administration of OK432 on the immuno-reactivities of regional lymph nodes in gastric cancer patients.

Authors:  E Yanagawa; T Toge; Y Yamaguchi; H Kuninobu; K Kuroi; Y Kegoya; N Baba; T Takayama; Y Sato
Journal:  Jpn J Surg       Date:  1991-05

8.  Effects of intraperitoneal administration of OK-432 for patients with advanced cancer.

Authors:  T Toge; H Yamada; K Aratani; A Kameda; K Kuroi; K Hisamatsu; T Hattori
Journal:  Jpn J Surg       Date:  1985-07

9.  Induction of tumor growth inhibitory factor (TGIF) in human mononuclear cells by OK-432, a streptococcal preparation.

Authors:  M Katano; H Yamamoto; T Mizoguchi; T Hisatsugu
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

10.  Tumour cell lines HT-29 and FaDu produce proinflammatory cytokines and activate neutrophils in vitro: possible applications for neutrophil-based antitumour treatment.

Authors:  Antonio Brú; Juan-Carlos Souto; Sonia Alcolea; Rosa Antón; Angel Remacha; Mercedes Camacho; Marta Soler; Isabel Brú; Amelia Porres; Luis Vila
Journal:  Mediators Inflamm       Date:  2010-02-11       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.